Darcy Frear

Darcy Frear, PhD, is an accomplished professional in the biopharmaceutical industry with a diverse background in project management, regulatory affairs, and healthcare consulting. Currently serving as Associate Director at BridgeBio since July 2022, Frear's previous roles include Senior Project Operations Manager at BioMarin Pharmaceutical Inc., where significant efficiencies were created in project tracking and policy communication, and Program Management roles at Genentech focusing on oncology regulatory submissions and expedited FDA filing strategies. Additional experience includes senior analyst positions at Fletcher Spaght, Inc., co-founding EarRose, and leadership roles in the Harvard Dragon Boat Team. Frear holds a PhD in Speech and Hearing Bioscience and Technology from Harvard University and a Bachelor of Engineering from Arizona State University.